Biosign Secures License Sale with the Release of an Enterprise Version of its Clinic Management Software

TORONTO, Jan. 20, 2015 /CNW/ - Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company") is pleased to announce that it has signed an initial one year user-based network license agreement with a substantial multi-national corporation, consisting of a large network of physiotherapy, paramedical and rehab clinics and an associated technology services group.  Under this contract Biosign will host the new Enterprise Version of its cloud-based ClinicServer practice management solution. The release of the Enterprise Version will significantly expand the market for the ClinicServer practice management solution. This innovative cloud solution will empower our new customer to manage its complex multi-jurisdictional clinical operations from a centralized and unified technology base. Use of this Enterprise Version will substantially increase their operational efficiencies and also facilitate a new level of electronic payment processing into their expanding network of clinics. The customer  has over 1500 clinics in its group of companies and our solution is currently being rolled-out to the North American division over the next two months.

On December 15th, 2014 ClinicServer began the general roll-out of the Enterprise Version of its cloud-based clinical practice management suite to its existing Canadian client base. As one of the first cloud-based services of its kind in the world, ClinicServer has earned worldwide credibility. ClinicServer's Enterprise Version offers clinic organizations of all sizes a host of new features designed to increase appointments, improve and standardize documentation, minimize claim rejections and enhance reporting. The new enterprise features make ClinicServer an ideal solution provider to large multi-location clinic organizations. With this Enterprise Version Biosign/ClinicServer can also offer Co-branding and White Label versions to a broad range of other large customers.  

The new ClinicServer Enterprise Version moves the product to a whole new plane and affirms Biosign/ClinicServer as a market-leading cloud-based practice management provider. The Enterprise Version was designed to deal with the unique challenges associated with the management and administration of the day-to-day operations of hundreds or thousands of clinical locations and features brand reporting capabilities, billing and eClaims modules.

Biosign CEO Mike Gross stated: "We are pleased to be working with this multi-national customer and its expanding Healthcare Network. ClinicServer now offers a whole new enterprise-level of cloud-based practice management software that we will continue to deploy in the Canadian market and we are now also uniquely positioned to aggressively expand our international presence as well as our partner relationships."

About Biosign Technologies Inc (TSXV: BIO) Biosign is a developer of world class healthcare software solutions targeted at the Home Care and Allied Health Care markets. The Company's various software divisions, including ClinicServer™, EESI Corporate Benefits, Qline Solutions and AioMed GmbH offer industry-leading Home Healthcare and Allied Health clinic management solutions to international companies and service providers worldwide. For more information on Biosign, please visit www.biosign.com.

Forward-Looking Statements

This release contains forward-looking statements. Forward-looking statements, without limitation, may contain the words believes, expects, anticipates, estimates, intends, plans, or similar expressions. Forward-looking statements are not guarantees of future performance. They involve risks, uncertainties and assumptions and Biosign's actual results could differ materially from those anticipated. Forward looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. In the context of any forward-looking information please refer to risk factors detailed in, as well as other information contained in the company's filings with Canadian securities regulators (www.sedar.com).

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE Biosign Technologies Inc.

Biosign Contact Information: Michael Gross, Acting CEO and Chairman, Biosign Technologies, Phone: [phone] ext. 201, Email: [email protected]